Bristol-Myers to Take a $3B Tax Hit in Q4 2017 Post author:Sam Post published:January 7, 2018 Post category:BioPharma The expense is primarily related to taxes on unremitted offshore earnings, the company said. Source: BioSpace You Might Also Like Teva Expected to Fire Up to 1,700 Workers in Israel, U.S. November 26, 2017 Daichi Sankyo Abandons Deal With Nektar Therapeutics After Drug Tanks in Europe December 12, 2017 Esperion's Cholesterol Drug Positive in PhIII Trial March 6, 2018